Partial recovery of renal function in patients treated by chronic dialysis
Keywords:
renal function recovery, dialysis, vasculitis, systemic lupus erythematosus, malignant hypertensionAbstract
Introduction. Renal function recovery (RFR), either complete or partial, in hemodialyzed (HD) or peritoneal dialyzed (PD) patients, is observed rather rarely. To a large extent it depends on primary disease leading to end-stage renal disease (ESRD), such as vasculitis, immunological disease associated with renal involvement, and primary malignant hypertension.
Aim. The aim of our study was presentation of three patients with end-stage renal disease (ESRD), needing renal replacement therapy (RRT). After immunosuppressive treatment performed in all patients, recovery of renal function was observed. The RRT was stopped in all patients.
Material and methods. The study was performed in three patients with end-stage renal disease. In two of three described cases the cause of ESRD was p-ANCA or c-ANCA positive vasculitis. In the third one the cause of ESRD was systemic lupus erythematosus (SLE) with renal involvement. In all described cases immunosuppressive therapy was performed parallelly to dialysotherapy. In two patients plasmapheresis was carried out as well.
Results. As a result of applying immunosuppressive treatment, together with renal replacement therapy, we obtained in all patients significant improvement in renal function, enabling us to withdraw them from the renal replacement therapy (RRT): in two cases of the transitional omission of peritoneal dialysotherapy, in one case of permanent ceasing of the treatment with repeatable haemodialyses.
Conclusions. Simultaneous application of chronic dialysis and intensive immunosuppressive treatment in patients suffering from vasculitis or systemic lupus erythematosus may lead to renal function recovery and to possibility to stopping dialysotherapy. In our study we observed renal function recovery more often in PD than in HD patients.
References
1. Craven AM, Hawley CM, McDonald SP. et al. Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with peritoneal dialysis. Perit Dial Int. 2007;27:184-91.
2. Lindblad AS, Nolph KD. Recovery of renal function in continuous ambulatory peritoneal dialysis: a study of National CAPD Registry data. Perit Dial Int. 1992;12(1):43-7.
3. Sekkarie MA, Port FK, Wolfe RA. et al. Recovery �rom end-stage renal disease. Am J Kidney Dis. 1990;15(1):61-5.
4. Simpson IJ. Partial recovery of renal function in SLE nephritis after two and a half years on dialysis. N Z Med J. 1987;100(835):696.
5. Rottemburg J, Issad B, Allouache M, Jacobs C. Recovery of renal function in patients treaeted by CAPD. Adv Perit Dial. 1989;5:63-6.
6. de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R. et al. Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2007;18(7):2189-97.
7. Goldstein A, Kliger AS, Finkelstein FO. Recovery of renal function and the discontinuation of dialysis in patients treated with continuous peritoneal dialysis. Perit Dial Int. 2003;23(2):151-6.
8. Cancarini GC, Brunori G, Camerini C. et al. Renal �unction recovery and maintenance of residual diuresis in CAPD and hemodialysis. Perit Dial Int. 1986;6(2):77-9.
9. Slot MC, Tervaert JWC, Franssen CFM. et al. Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int. 2003;63:670-7.
10. Hauer HA, Bajema IM, Van Houwelingen HC. et al. Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico- histopathological analysis of 96 patients. Kidney Int. 2002;62(5):1732-42.
11. Booth AD, Almond MK, Burns A. et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis. 2003;41(4):776-84.
12. de Lind van Wijngaarden RAF, Hauer HA, Wolterbeek R. et al. Clinical and Histologic Determinants of Renal Outcome in ANCA-Associated Vasculitis: a Prospective Analysis of 100 Patients with Severe Renal Involvement. J Am Soc Nephrol. 2006;17:2264-74.
13. Neumann I, Kain R, Regele H. et al. Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis. Nephrol Dial Transplant. 2005;20(1):96-104.
14. Weidner S, Geuss S, Hafezi-Rachti S. et al. ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant. 2004;19(6):1403-11.
15. Altieri P, Sau G, Cao R et al. Immunosuppressive treatment in dialysis patients. Nephrol Dial Transplant. 2002;17:2-9.